Notice: This company has been marked as potentially delisted and may not be actively trading. Champions Oncology (CSBR) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrends Champions Oncology (NASDAQ:CSBR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage46.98%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$58,621.64Number OfInsiders Selling(Last 12 Months)0 Get CSBR Insider Trade Alerts Want to know when executives and insiders are buying or selling Champions Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CSBR Insider Buying and Selling by Quarter Ad Porter & CompanyAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.I urge you to watch it now. Champions Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/12/2024Daniel Newman MendelsonDirectorBuy1,000$6.50$6,500.00 1/10/2024Daniel Newman MendelsonDirectorBuy2,944$6.31$18,576.64 1/8/2024Daniel Newman MendelsonDirectorBuy1,000$6.15$6,150.00 1/5/2024Daniel Newman MendelsonDirectorBuy2,000$6.09$12,180.00 1/3/2024Daniel Newman MendelsonDirectorBuy500$5.83$2,915.00 12/21/2023Daniel Newman MendelsonDirectorBuy2,500$4.92$12,300.00 (Data available from 1/1/2013 forward) CSBR Insider Trading Activity - Frequently Asked Questions Who is on Champions Oncology's Insider Roster? The list of insiders at Champions Oncology includes Daniel Newman Mendelson, and Ronnie Morris. Learn more on insiders at CSBR. What percentage of Champions Oncology stock is owned by insiders? 46.98% of Champions Oncology stock is owned by insiders. Learn more on CSBR's insider holdings. Which Champions Oncology insiders have been buying company stock? The following insiders have purchased CSBR shares in the last 24 months: Daniel Newman Mendelson ($224,952.64), and Ronnie Morris ($50,023.28). How much insider buying is happening at Champions Oncology? Insiders have purchased a total of 51,926 CSBR shares in the last 24 months for a total of $274,975.92 bought. More Insider Trading Tools from MarketBeat Related Companies Jasper Therapeutics Insider Ownership C4 Therapeutics Insider Ownership 4D Molecular Therapeutics Insider Ownership iTeos Therapeutics Insider Ownership enGene Insider Ownership Atyr PHARMA Insider Ownership Ocugen Insider Ownership Artiva Biotherapeutics Insider Ownership Inhibikase Therapeutics Insider Ownership Lexeo Therapeutics Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:CSBR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Champions Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Champions Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CSBR Stock Alerts